Investigation of Bioactivity of Estragole Isolated from Basil Plant on Brain Cancer Cell Lines Using Nuclear Method

Curr Radiopharm. 2023;16(2):140-150. doi: 10.2174/1874471016666230110144021.

Abstract

Background: In recent years, there has been a significant increase in studies investigating the potential use of plant-origin products in the treatment and diagnosis of different types of cancer.

Methods: In this study, Estragole (EST) was isolated from basil leaves via ethanolic extraction using an 80% ethanol concentration. The isolation process was performed using the High Performance Liquid Chromatography (HPLC) method. The EST isolated from the basil plant was radiolabeled with 131I using the iodogen method. Quality control studies of the radiolabeled EST (131IEST) were carried out by using Thin Layer Radio Chromatography (TLRC). Next, in vitro cell, culture studies were done to investigate the bio-affinity of plant-originated EST labeled with 131I on human medulloblastoma (DAOY) and human glioblastoma-astrocytoma (U-87 MG) cell lines. Finally, the cytotoxicity of EST was determined, and cell uptake of 131I-EST was investigated on cancer cell lines by incorporation studies.

Results: As a result of these studies, it has been shown that 131I-EST has a significant uptake on the brain cells.

Conclusion: This result is very satisfying, and it has encouraged us to do in vivo studies for the molecule in the future.

Keywords: Basil plant; estragole (EST); estragole radiolabeled with 131I (131I-EST); human glioblastoma-astrocytoma (U87-MG); human medulloblastoma (DAOY); iodine-131 (131I).

MeSH terms

  • Brain Neoplasms*
  • Humans
  • Ocimum basilicum* / chemistry
  • Radiopharmaceuticals

Substances

  • estragole
  • Iodine-131
  • Radiopharmaceuticals